ArticleMolecular psychiatry2025
Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography.
Abstract read
In one paragraph
Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Age and sex-dependent alteration in AMPA receptor density in living human brain.European journal of nuclear medicine and molecular imaging · 2026Article
- In vivo imaging of synaptic density in psychotropic-free adults with autism spectrum disorder: a [¹¹C]UCB-J PET study.Molecular psychiatry · 2026Article
- Limitations of pro-drug-like PET tracers for brain imaging.Molecular psychiatry · 2026Article
- NADPH oxidase-1 suppression prolongs the antidepressant-like effect of ketamine.Molecular psychiatry · 2026Article
- The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depression.Molecular psychiatry · 2026Article
- The development of positron emission tomography (PET) tracer for glutamate AMPA receptors and its application to human biology and clinics.Psychiatry and clinical neurosciences · 2026Review
- Aniracetam restores the excitation-inhibition balance of neurotransmitters in the prefrontal cortex of mice with ADHD.Scientific reports · 2026Article
- Molecular and Neuroimaging Correlates of Bipolar Disorder: Linking Inflammation, Mitochondria, and Brain Circuitry.International journal of molecular sciences · 2026Review
- Glutamate, Contextual Insensitivity, and Disorganized Speech in First-Episode Schizophrenia: A 7T Magnetic Resonance Spectroscopy Study.Biological psychiatry global open science · 2025Article
- First-in-Human Study ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- Exogenous GABA Alleviates Tourette Syndrome-Like Behavior in Sprague-Dawley Rats by Altering Gut Microbiota and Striatum Metabolism.Neuropsychiatric disease and treatment · 2025Article
- Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution.Frontiers in neural circuits · 2025Article
- Systemic increase of AMPA receptors associated with cognitive impairment of long COVID.Brain communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
35 authors.
Mai Hatano *Department of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Waki Nakajima *Department of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hideaki Tani *Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Hiroyuki UchidaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0002-0628-7036
Tomoyuki MiyazakiDepartment of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Tetsu ArisawaRadioisotope Research Center, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yuuki TakadaDepartment of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Sakiko TsugawaDepartment of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Akane SanoDepartment of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kotaro NakanoDepartment of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Tsuyoshi EiroDepartment of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hiroki AbeDepartment of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Akira SudaDepartment of Psychiatry, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Takeshi AsamiDepartment of Psychiatry, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Akitoyo HishimotoDepartment of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan.
Nobuhiro NagaiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Teruki KoizumiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Shinichiro NakajimaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0002-2601-2195
Shunya KurokawaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0001-6451-5263
Yohei OhtaniDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Kie TakahashiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Yuhei KikuchiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0003-4656-5763
Taisuke YatomiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Shiori HondaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Masahiro JinzakiDepartment of Radiology, Keio University School of Medicine, Tokyo, Japan.
Yoji HiranoDepartment of Psychiatry, Division of Clinical Neuroscience, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.ORCID 0000-0001-6847-9677
Ryo MitomaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyusyu University, Fukuoka, Japan.
Shunsuke TamuraDepartment of Psychiatry, Division of Clinical Neuroscience, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Shingo BabaDepartment of Clinical Radiology, Graduate School of Medical Sciences, Kyusyu University, Fukuoka, Japan.
Osamu TogaoDepartment of Clinical Radiology, Graduate School of Medical Sciences, Kyusyu University, Fukuoka, Japan.
Hirotaka KosakaDepartment of Psychiatry, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.ORCID 0000-0003-2210-5025
Hidehiko OkazawaBiomedical Imaging Research Center, University of Fukui, Fukui, Japan.ORCID 0000-0001-7046-3383
Yuichi KimuraFaculty of Informatics, Cyber Informatics Research Institute, Kindai University, Higashi-Osaka, Japan.
Masaru MimuraDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Takuya TakahashiDepartment of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. takahast@yokohama-cu.ac.jp.ORCID 0000-0001-6523-0622
Funding
Japan Agency for Medical Research and Development (AMED) JP18dm0207023, JP20dm0107124, JP22dm0207072
Abstract
Synaptic phenotypes in living patients with psychiatric disorders are poorly characterized. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is a fundamental component for neurotransmission. We recently developed a positron emission tomography (PET) tracer for AMPAR, [
Indexed as
Mental DisordersReceptors, AMPAAdultAutism Spectrum DisorderBipolar DisorderBrainCarbon RadioisotopesFemaleHumansMaleMiddle AgedPositron-Emission TomographySchizophreniaCarbon RadioisotopesReceptors, AMPA
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.